跳至主要内容
临床试验/NCT05558865
NCT05558865已完成不适用

Evaluating the Effectiveness of a Digital Therapeutic (Somnovia) for People With Insomnia Disorder - a Randomized Controlled Trial

Gaia AG1 个研究点 分布在 1 个国家目标入组 290 人开始时间: 2022年11月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Gaia AG
入组人数
290
试验地点
1
主要终点
Insomnia Severity Index (ISI)

研究概览

简要总结

The trial aims to evaluate the effectiveness of a novel digital health application (somnovia), which was designed to increase sleep quality in persons with insomnia disorder. Therefore, 290 people with insomnia disorder will be recruited and randomized to two groups: (1) a control group, in which they may engage with any treatment for insomnia disorder and are offered access to somnovia after a delay of 6 months (i.e., Care-as-Usual [CAU]), or (2) to a treatment group that immediately receives 6-month access to somnovia and may also use CAU. The primary outcome measure is the score of the Insomnia Severity Index (ISI), collected at three months post-baseline.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •diagnosis of chronic insomnia
  • •impaired quality of sleep (Insomnia Severity Index Score ≥ 10)

排除标准

  • 未提供

研究组 & 干预措施

somnovia

Experimental

somnovia is a digital health application for people with Insomnia Disorder. Content is continuously adapted to patients' concerns and needs. somnovia is a comprehensive program, which is conceptually and substantially based on the Cognitive Behavioral Therapy for Insomnia (CBT-I) used in patients with Insomnia Disorder. It contains interactive dialogues that can be accessed via computer or smartphone, illustrations, audio recordings and motivating text messages. Techniques to cope with insomnia symptoms (e.g., psychoeducation about causes and basic emotional needs in addition to relevant strategies to improve sleep quality) are conveyed in interactive sequences that are accompanied by audio recordings, illustrations, and worksheets. Patients are also prompted to regularly complete brief symptom severity self-monitoring questionnaires. Optional daily text messages with motivational content accompany the program. The program can be accessed for 365 days after registration.

干预措施: somnovia (Behavioral)

Care as Usual

No Intervention

Care as Usual: In the CAU control group, participants are free to continue to engage with any treatment they require. However, they will be offered access to somnovia after 6 months post-baseline.

结局指标

主要结局

Insomnia Severity Index (ISI)

时间窗: 3 months after randomization

The ISI is a 7-item patient-reported outcome measure (PROM) assessing the nature, severity, and impact of insomnia on a 5-point Likert scale to rate each item from 0 (no problem) to 4 (very severe problem).

次要结局

  • Insomnia Severity Index (ISI)(6 months after randomization)
  • Patient Health Questionnaire (PHQ-9)(3 months and 6 months after randomization)
  • Responder Rate on Insomnia Severity Index(3 months after randomization)
  • Remission Rate on Insomnia Severity Index(3 months after randomization)
  • Generalized Anxiety Disorder Assessment (GAD-7)(3 months and 6 months after randomization)
  • Work and Social Assessment Scale (WSAS)(3 months and 6 months after randomization)

研究者

发起方
Gaia AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验